All posts by: Michael Zand

Novel harvesting method rapidly produces superior stem cells for transplantation
Medical Xpress
A new method of harvesting stem cells for bone marrow transplantation – developed by a team of investigators from the Massachusetts General Hospital (MGH) Cancer Center and the Harvard Stem Cell Institute – appears to accomplish two goals: making the …
Stem cells ‘will enable us to live to 200’ – The ScotsmanThe Scotsman
New Data Published in Journal Cell Show Robust Mobilization of Highly Engraftable Stem Cells in Mouse Models with …Business Wire (press release)
North America Stem Cell Media Market by Hematopoietic …Medgadget (blog)
MilTech –Expert Herald –ExpressObserver
all 29 news articles »

New Gene Therapy Could Regenerate Brain Tissue, Fix Neurological Diseases
Futurism
A new study has demonstrated the advantages of a gene therapy transplantation technique that seeks to repopulate the brain’s supply of immune cells, called microglia. By introducing genetically engineered microglia into patients with neurodegenerative …

and more »

New Gene Therapy Could Regenerate Brain Tissue, Fix Neurological Diseases
Futurism
A new study has demonstrated the advantages of a gene therapy transplantation technique that seeks to repopulate the brain’s supply of immune cells, called microglia. By introducing genetically engineered microglia into patients with neurodegenerative …

and more »

Synthetic Biology Market Share will Increase US$ 38 Billion By 2020
Finance Wire
The synthetic biology market is expected to exceed more than US$38 billion by 2020.
Jean PeccoudThe Conversation US
‘Cyberbiosecurity’ and protecting the life sciences – Phys.orgPhys.Org

all 4 news articles »

Researchers Learn to Route Gene Therapy Directly into Brain
Scicasts (press release) (blog)
The technique, which could be used to transplant donor-matched haematopoietic stem cells (HSCs) or a patient’s own genetically-engineered HSCs into the brain, was reported in Science Advances today by researchers from the Dana-Farber/Boston Children’s …

Scottish Biotech and bluebird bio to Develop Next Generation CAR–T Cells
Labiotech.eu (blog)
TC Biopharm has scored a deal with bluebird bio for the development of the next generation of CAR–T cells, a technology giving new hope to cancer patients. With the first two CAR-T therapies now in the market, the way we treat cancer is changing. This …
Taking on gamma delta T cells, bluebird pays $16M for TC BioPharm’s tumor invading tech platformEndpoints News
bluebird bio and TC BioPharm Announce Strategic Collaboration to Research and Develop Gamma Delta CAR T Cell …Business Wire (press release)
Life sciences group TC BioPharm secures $16m US tie-up to develop new cancer treatmentsinsider.co.uk
Seeking Alpha –NB Herard
all 6 news articles »

Scientists Control Stem Cells‘ Change to Neurons, a Potentially Valuable Tool for Huntington’s
Huntington’s Disease News
Embryonic stem cells have been seen as a potential therapeutic strategy for several diseases. However, the manipulation of these cells has been a challenge for scientists due to their complex regulatory systems. In a study published in Nature …